The Latin America, Middle East and Africa Hemostats Market is expected to witness market growth of 8.3% CAGR during the forecast period (2022-2028).
The primary cause of illness and mortality in industrialized countries is atherosclerotic plaque rupture, which results in thrombosis of the coronary and cerebral arteries. The molecular characterization of vascular and hemostatic variables has made significant strides over the last two decades. These developments improve the knowledge of the processes involved in the formation of hemostatic and thrombotic plugs.
It is essential that the surgical team employ solid clinical judgement when choosing an agent or combination of agents to maximize patient outcomes because timely delivery is a key component in attaining hemostasis. The size and shape of the wound, the severity of the bleeding, the agent's effectiveness, any potential side effects, the application method, user friendliness, timing requirements, & storage needs are all important factors to take into consideration when choosing a hemostat.
If residual bleeding continues after the use of conventional methods for hemorrhage control during surgical operations, a wide range of hemostats are available as a supplemental strategy to enhance hemostasis. Some are referred to as "active agents" because they include thrombin and fibrinogen and actively contribute to the formation of a fibrin clot at the conclusion of the coagulation cascade, whereas others need the coagulation system to function properly.
Due to Dubai's rapid urban expansion and ever-increasing population, a huge influx of medical tourists who rely on Dubai's top-notch hospitals and specialty clinics for their treatments has raised the demand for quality health services. Dubai is a major hub for the healthcare business, ready to serve not just the local market but also larger regional demand owing to its high-tech medical infrastructure and a growing number of public and private healthcare organizations. Currently, among the most popular medical specializations for tourists seeking treatment in Dubai are sports medicine, orthopedics, dermatology & skin care, dentistry, and reproductive treatment.
The Brazil market dominated the LAMEA Hemostats Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $64.2 million by 2028. The Argentina market is experiencing a CAGR of 8.9% during (2022 - 2028). Additionally, The UAE market is expected to showcase a CAGR of 8% during (2022 - 2028).
Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. Based on Formulation, the market is segmented into Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others. Based on Type, the market is segmented into Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.
The primary cause of illness and mortality in industrialized countries is atherosclerotic plaque rupture, which results in thrombosis of the coronary and cerebral arteries. The molecular characterization of vascular and hemostatic variables has made significant strides over the last two decades. These developments improve the knowledge of the processes involved in the formation of hemostatic and thrombotic plugs.
It is essential that the surgical team employ solid clinical judgement when choosing an agent or combination of agents to maximize patient outcomes because timely delivery is a key component in attaining hemostasis. The size and shape of the wound, the severity of the bleeding, the agent's effectiveness, any potential side effects, the application method, user friendliness, timing requirements, & storage needs are all important factors to take into consideration when choosing a hemostat.
If residual bleeding continues after the use of conventional methods for hemorrhage control during surgical operations, a wide range of hemostats are available as a supplemental strategy to enhance hemostasis. Some are referred to as "active agents" because they include thrombin and fibrinogen and actively contribute to the formation of a fibrin clot at the conclusion of the coagulation cascade, whereas others need the coagulation system to function properly.
Due to Dubai's rapid urban expansion and ever-increasing population, a huge influx of medical tourists who rely on Dubai's top-notch hospitals and specialty clinics for their treatments has raised the demand for quality health services. Dubai is a major hub for the healthcare business, ready to serve not just the local market but also larger regional demand owing to its high-tech medical infrastructure and a growing number of public and private healthcare organizations. Currently, among the most popular medical specializations for tourists seeking treatment in Dubai are sports medicine, orthopedics, dermatology & skin care, dentistry, and reproductive treatment.
The Brazil market dominated the LAMEA Hemostats Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $64.2 million by 2028. The Argentina market is experiencing a CAGR of 8.9% during (2022 - 2028). Additionally, The UAE market is expected to showcase a CAGR of 8% during (2022 - 2028).
Based on Application, the market is segmented into Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, and Others. Based on Formulation, the market is segmented into Matrix & Gel, Sheet & Pad, Powder, Sponge, and Others. Based on Type, the market is segmented into Thrombin Based, Combination, Oxidized Regenerated Cellulose Based, Gelatin Based, Collagen Based, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Baxter International, Inc., B. Braun Melsungen AG, Teleflex, Inc., Medtronic PLC, Johnson & Johnson, Pfizer, Inc., Stryker Corporation, Integra LifeSciences Holdings Corporation, and Artivion, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
By Formulation
- Matrix & Gel
- Sheet & Pad
- Powder
- Sponge
- Others
By Type
- Thrombin Based
- Combination
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Baxter International, Inc.
- B. Braun Melsungen AG
- Teleflex, Inc.
- Medtronic PLC
- Johnson & Johnson
- Pfizer, Inc.
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Artivion, Inc.
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Hemostats Market by Application
Chapter 4. LAMEA Hemostats Market by Formulation
Chapter 5. LAMEA Hemostats Market by Type
Chapter 6. LAMEA Hemostats Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton, Dickinson and Company
- Baxter International, Inc.
- B. Braun Melsungen AG
- Teleflex, Inc.
- Medtronic PLC
- Johnson & Johnson
- Pfizer, Inc.
- Stryker Corporation
- Integra LifeSciences Holdings Corporation
- Artivion, Inc.
Methodology
LOADING...
